Efficiency of metabolite therapy for neuro­vegetative disorders in children with acute respiratory infections


Khlypovka Yu.N., Ploskireva A.A., Ruzhen­tsova T.A., Nartsissov Ya.R., Maksimova L.N.

1 Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia; 2 Medical Research and Production Complex «BIOTICS», Moscow, Russia; 3 Research Institute of Cytochemistry and Molecular Pharmacology, Moscow, Russia
Objective. To evaluate the efficacy, tolerability, and safety of using a combination metabolite drug containing L-glutamic acid, glycine and L-cystine in comparison with basic therapy in the correction of neurovegetative disorders in children with acute respiratory infections.
Subjects and methods. The investigation enrolled 53 patients aged 12 to 18 years with acute respiratory infections who had clinical manifestations of neurovegetative disorders. The patients were randomized into 2 groups: a study group (n = 27) and a control group (n = 26). The study group received the metabolite drug as part of combination therapy; the control group had the basic therapy. The duration of treatment was 30 days. All the patients underwent comprehensive assessment of the neurovegetative status at admission and at 1-month follow-up.
Results. There were no patients with obvious asthenia in the study group at the follow-up, while the proportion of such patients was 3.8% in the comparison group. After the end of treatment, 70% of the patients in the study group were diagnosed with a predominance of sympathetic tone of the autonomic nervous system; these were only 42.3% in the comparison group (p < 0.05). At the same time, there was no obvious abnormal sympathetic regulation when the drug was used (unlike the comparison group where this was noted in 34.6% of cases; p < 0.01), suggesting that the functioning processes of the neuroregulatory system were restored. After treatment completion, the children in the study group had diminished central nervous break-down, enhanced working efficiency, improved performance, and lower-level anxiety. No adverse events or abnormal hemogram readings were recorded after completing the therapy cycle.
Conclusion. The investigation showed the efficacy and safety of using the metabolite drug containing L-glutamic acid, glycine, and L-cystine in children with neurovegetative disorders in the presence of acute respiratory infections. The therapy contributed to the reduced severity of post-infection asthenia.

Literature


  1. [Infectious morbidity in the Russian Federation in January–December 2016 (according to form № 1 «Information on infectious and parasitic diseases»)]. http://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php? ELEMENT_ID=7804. Accessed July 7, 2017. (In Russ.).
  2. Kalyuzhin O.V. [Acute respiratory viral infections. Modern challenges. Antiviral response. Immunoprophylaxis and immunotherapy]. Мoscow: Meditsinskoye informatsionnoye agentstvo, 2014. 144 р. (In Russ.).
  3. Nemkova S.А. [Modern approaches to post-infectious asthenia treatment in children and adolescents]. Pediatriуa. Zhurnal imeni G.N. Speranskogo 2016; 95(6): 199–204. (In Russ.). DOI:10.24110/0031-403X-2016-95-6-199-204.
  4. Gorelov A.V., Grigorovich M.S. [Acute enteric infections in children: long-term outcomes, the factors determining them. Optimization of rehabilitation]. Кirov: Vesi, 2012. 206 p. (In Russ.).
  5. Levchenko N.V., Bogomolova I.К., Chavanina S.А. [Results of follow-up study of A/H1N1/09 influenza among children]. Zabajkal’skij medicinskij vestnik. 2014; (2): 23–7. (In Russ.).
  6. Godin N.V. [Neurometabolic therapy of acute cerebral circulatory disorders]. Central’nij nauchnij vestnik 2016; 1(13): 9–13. (In Russ.).
  7. Potupchik T.V., Evert L.S., Veselova O.F., Narcissov Ja.R. [Method of prevention and correction of disorders of adaptive processes in children]. Meditsinskaya sestra 2016; (3): 54–5. (In Russ.).
  8. Samohina I., Basargina Е., Semenova G., Kurbatova О., Maksimova L., Fedorova N., Miroshkina L., Izmajlova T., Petrichuk S. [Possibilities of correcting metabolic disorders in children with chronic heart failure]. Vrach 2016; (1): 38–43. (In Russ.).
  9. Kolesnichenko L.S., Kulinskij V.I., Gorina A.S. [Amino acids and their metabolites in blood and urine in the minimal cerebral dysfunction]. Voprosy medicinskoj himii 1999; 45(1): 58–64. (In Russ.).
  10. Alekseeva E.V. [Glutamic acid changes in plasma of critical patients with hypoxia]. Vestnik sovremennoj klinicheskoj mediciny 2016; 9(5): 14–25. (In Russ.).
  11. Brose S.A., Marquardt A.L., Golovko M.Y. Fatty acid biosynthesis from glutamate and glutamine is specifically induced in neuronal cells under hypoxia. J. Neurochem. 2014; 129(3): 400–12.
  12. Levashov P.A., Matolygina D.A., Ovchinnikova E.D., Atroshenko D.L., Savin S.S., Belogurova N.G., Smirnov S.A., Tishkov V.I., Levashov A.V. [Bakteriolytic activity of human interleukin-2, chicken egg lysozyme in the presence of potential effectors]. Acta Naturae 2017; (8): 87–92. (In Russ.).
  13. Simakov А.. Panina М., Chekuldaeva L., Obuchova S. [Eltacin treatment in children with autonomic dysfunction]. Vrach 2015; (9): 21–4. (In Russ.).
  14. Maksimova L.N., Zaslavskaya R.М., Kalinina Е.V., Narcissov Ya.R. [Clinical experience of application of the original metabolic drug Eltacin in patients with chronic heart failure]. Effektivnaja farmakoterapija 2011; 5(16): 40–3. (In Russ.).
  15. Neudachin Е.V. [A basic understanding of the syndrome of vegetative dystonia in children and principles of treatment]. Praktika pediatra 2008; (3): 5–10. http://medi.ru/doc/j0108035.htm. (In Russ.).
  16. Shac I.K. [Psychological support critically ill child]. St. Petersburg: Rech Publ., 2010. 192 p. (In Russ.).
  17. Spilberger Ch.D., Hanin Ju.L. [Assessment of anxiety. In: Dermanova I.B., ed. Diagnostics of emotional and moral development]. St. Petersburg: Rech Publ., 2002; 124–6. (In Russ.).
  18. Nemov R.S. [Psychology. A textbook for students of higher pedagogical educational institutions. In 3 books. 4th ed.]. Мoscow: VLADOS, 2003. V. 3. 640 p. (In Russ.).
  19. Luriya A.R. [Memorizing 10 words. The almanac of psychological tests]. Мoscow, 1995; 92–4. (In Russ.).
  20. Petrie A., Sebin K. [Medical statistics at a glance]. Мoscow: GEOTAR-Media, 2010. 169 p. (In Russ.).


About the Autors


For correspondence:
Tatiana A. Ruzhentsova, МD, Leading Researcher, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare
Address: 3a, Novogireevskaya St., Moscow 111123, Russia
Telephone: +7(495) 672-11-58
E-mail: ruzhencova@gmail.com.
Information about the authors:
Yulia N. Hlipovka, Junior Researcher, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia; e-mail: ve-stu@mail.ru
Antonina A. Ploskireva, MD, Senior Researcher, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia; e-mail: antonina@ploskireva.com.
Yaroslav R. Narcissov, Cand. Phys.-Mat. Sci., Director, Medical Research and Production Complex «BIOTICS», Moscow, Russia; e-mail:  medicina@biotic. dol.ru
Ludmila N. Maksimova, Cand. Med. Sci., Deputy Director for Clinical Pharmacology, Research Institute of Cytochemistry and Molecular Pharmacology, Moscow, Russia; e-mail: yarosl@ biotic.dol.ru


Similar Articles


Бионика Медиа